首页> 外文期刊>Digestive Diseases and Sciences >Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
【24h】

Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes

机译:联合糖探针评估肝硬化腹水患者的肠通透性和吸收

获取原文
获取原文并翻译 | 示例
           

摘要

Gastrointestinal dysfunction in patients with cirrhosis may contribute to complications such as malnutrition and spontaneous bacterial peritonitis. To determine whether cirrhotic patients with ascites have altered intestinal function, we compared intestinal permeability and absorption in patients with liver disease and normal subjects. Intestinal permeability and absorption were investigated in 66 cirrhotic patients (48 with ascites, 18 without ascites) and 74 healthy control subjects. Timed recovery of 3-O-methyl-D-glucose, D-xylose, L-rhamnose, and lactulose in urine following oral administration was measured in order to assess active and passive carrier-mediated, and nonmediated, absorptive capacity, as well as intestinal large-pore/small-pore (lactulose/rhamnose) permeability. Test sugars were measured by quantitative thin-layer chromatography and results are expressed as a percentage of test dose recovered in a 5-h urine collection. Sugar excretion ratios relating to small intestinal permeability (lactulose/rhamnose) and absorption (rhamnose/3-O-methyl-D-glucose) were calculated to avoid the effects of nonmucosal factors such as renal clearance, portal hypertension, and ascites on the recovery of sugar probes in urine. Compared with normal subjects, the mean lactulose/rhamnose permeability ratio in cirrhotic patients with ascites was significantly higher (0.058 vs. 0.037, P < 0.001) but not in cirrhotic patients without ascites (0.041 vs. 0.037). Cirrhotic patients with ascites had significantly lower mean recoveries of 3-O-methyl-D-glucose (23.0 vs. 49.1%; P < 0.001), D-xylose (18.8 vs. 34.5%; P < 0.001), L-rhamnose (4.0 vs. 9.1%; P < 0.001), and lactulose (0.202 vs. 0.337%; P < 0.001) than normal subjects. However, the mean rhamnose/3-O-methyl-D-glucose ratio was the same in cirrhotic patients with ascites as normal subjects (0.189 vs. 0.189), indicating that the reduction in probe recovery was due to nonmucosal factors. Compared with normal subjects, cirrhotic patients with ascites have abnormal intestinal permeability, measured by urinary lactulose/rhamnose excretion, and normal small intestinal absorption, assessed by the urinary rhamnose/3-O-methyl-D-glucose ratio. Low urine recovery of sugar probes found in cirrhotic patients appears to be the result of nonintestinal factors affecting clearance rather than reduced intestinal absorption.
机译:肝硬化患者的胃肠道功能障碍可能会导致营养不良和自发性细菌性腹膜炎等并发症。为了确定肝硬化腹水患者的肠道功能是否改变,我们比较了肝病患者和正常受试者的肠道通透性和吸收率。在66例肝硬化患者(48例有腹水,18例无腹水)和74例健康对照者中调查了肠道通透性和吸收率。测量口服后尿液中3-O-甲基-D-葡萄糖,D-木糖,L-鼠李糖和乳果糖的定时回收率,以评估主动和被动载体介导的和非介导的吸收能力,以及肠道的大孔/小孔(乳果糖/鼠李糖)通透性。通过定量薄层色谱法测量测试糖,结果表示为在5小时尿液收集中回收的测试剂量的百分比。计算与小肠通透性(乳果糖/鼠李糖)和吸收(鼠李糖/ 3-O-甲基-D-葡萄糖)有关的糖排泄率,以避免肾脏肾脏清除率,门脉高压和腹水等非黏膜因子对恢复的影响。尿液中的糖探针的数量。与正常人相比,肝硬化腹水患者的平均乳果糖/鼠李糖通透性比率显着更高(0.058 vs. 0.037,P <0.001),但在没有腹水的肝硬化患者中则没有(0.041 vs. 0.037)。肝硬化腹水患者的3-O-甲基-D-葡萄糖平均回收率明显较低(23.0比49.1%; P <0.001),D-木糖(18.8比34.5%; P <0.001),L-鼠李糖(与正常受试者相比,分别为4.0%vs.9.1%; P <0.001)和乳果糖(0.202 vs. 0.337%; P <0.001)。然而,腹水型肝硬化患者的平均鼠李糖/ 3-O-甲基-D-葡萄糖比率与正常受试者相同(0.189比0.189),这表明探针回收率的降低是由于非粘膜因素引起的。与正常受试者相比,肝硬化腹水患者的尿渗透率(通过尿乳果糖/鼠李糖排泄量测定)和小肠吸收正常(通过尿鼠李糖/ 3-O-甲基-D-葡萄糖比值评估)。在肝硬化患者中发现的糖探针尿回收率低似乎是由于非肠道因素影响清除率而不是肠道吸收减少所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号